The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking

Autor: Marten H. Hofker, Johannes H.M. Levels, Marieke Smit, Ko Willems van Dijk, Ezra Burstein, Melinde Wijers, Helene Klug, Jan Albert Kuivenhoven, Alina Fedoseienko, Daphne Dekker, Daniel D. Billadeau, Nicolette C. A. Huijkman, Jan M. van Deursen, Justina C. Wolters, Marit Westerterp, Bart van de Sluis, Niels J. Kloosterhuis, Aloys Schepers
Přispěvatelé: Lifestyle Medicine (LM), Center for Liver, Digestive and Metabolic Diseases (CLDM), Translational Immunology Groningen (TRIGR), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), AGEM - Digestive immunity, ACS - Diabetes & metabolism, Experimental Vascular Medicine, AGEM - Endocrinology, metabolism and nutrition
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
HYPERLIPOPROTEINEMIA
CLEARANCE
Physiology
Gene Expression
chemistry.chemical_compound
0302 clinical medicine
DOMAIN
Receptor
Chromatography
High Pressure Liquid

Mice
Knockout

TRANSGENIC MICE
hypercholesterolemia
CHOLESTEROL
Hep G2 Cells
LRP1
Cell biology
DENSITY-LIPOPROTEIN RECEPTOR
Protein Transport
Knockout mouse
lipids (amino acids
peptides
and proteins)

Cardiology and Cardiovascular Medicine
Low Density Lipoprotein Receptor-Related Protein-1
MULTIPROTEIN COMPLEX
Atherosclerosis
Endosome
Hypercholesterolemia
Liver
Mice Transgenic
mice
PROTEINS
ENDOCYTOSIS
Endosomes
liver
Cell Line
03 medical and health sciences
Cell surface receptor
Animals
Humans
endosome
Triglycerides
Adaptor Proteins
Signal Transducing

transgenic
Cholesterol
Tumor Suppressor Proteins
Cholesterol
LDL

Cytoskeletal Proteins
HEK293 Cells
030104 developmental biology
WASH COMPLEX
Receptors
LDL

chemistry
LDL receptor
atherosclerosis
Carrier Proteins
Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]
Gene Deletion
030217 neurology & neurosurgery
Lipoprotein
Zdroj: Circulation research, 122(12), 1648-1660. LIPPINCOTT WILLIAMS & WILKINS
Circulation Research, 122, 12, pp. 1648-1660
Circulation Research, 122(12), 1648-1660
Circulation Research, 122, 1648-1660
Circ. Res. 122, 1648-1660 (2018)
Circulation research, 122(12), 1648-1660. Lippincott Williams and Wilkins
ISSN: 0009-7330
Popis: Rationale: COMMD (copper metabolism MURR1 domain)-containing proteins are a part of the CCC (COMMD–CCDC22 [coiled-coil domain containing 22]–CCDC93 [coiled-coil domain containing 93]) complex facilitating endosomal trafficking of cell surface receptors. Hepatic COMMD1 inactivation decreases CCDC22 and CCDC93 protein levels, impairs the recycling of the LDLR (low-density lipoprotein receptor), and increases plasma low-density lipoprotein cholesterol levels in mice. However, whether any of the other COMMD members function similarly as COMMD1 and whether perturbation in the CCC complex promotes atherogenesis remain unclear. Objective: The main aim of this study is to unravel the contribution of evolutionarily conserved COMMD proteins to plasma lipoprotein levels and atherogenesis. Methods and Results: Using liver-specific Commd1 , Commd6 , or Commd9 knockout mice, we investigated the relation between the COMMD proteins in the regulation of plasma cholesterol levels. Combining biochemical and quantitative targeted proteomic approaches, we found that hepatic COMMD1, COMMD6, or COMMD9 deficiency resulted in massive reduction in the protein levels of all 10 COMMDs. This decrease in COMMD protein levels coincided with destabilizing of the core (CCDC22, CCDC93, and chromosome 16 open reading frame 62 [C16orf62]) of the CCC complex, reduced cell surface levels of LDLR and LRP1 (LDLR-related protein 1), followed by increased plasma low-density lipoprotein cholesterol levels. To assess the direct contribution of the CCC core in the regulation of plasma cholesterol levels, Ccdc22 was deleted in mouse livers via CRISPR/Cas9-mediated somatic gene editing. CCDC22 deficiency also destabilized the complete CCC complex and resulted in elevated plasma low-density lipoprotein cholesterol levels. Finally, we found that hepatic disruption of the CCC complex exacerbates dyslipidemia and atherosclerosis in ApoE3*Leiden mice. Conclusions: Collectively, these findings demonstrate a strong interrelationship between COMMD proteins and the core of the CCC complex in endosomal LDLR trafficking. Hepatic disruption of either of these CCC components causes hypercholesterolemia and exacerbates atherosclerosis. Our results indicate that not only COMMD1 but all other COMMDs and CCC components may be potential targets for modulating plasma lipid levels in humans.
Databáze: OpenAIRE